Jun Shinozuka Selected Research

Jun Shinozuka Research Topics

2	COVID-19 01/2022 - 01/2022
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 03/2023
1	Iron Deficiencies 01/2022
1	Hemolytic Anemia 01/2022
1	Iron-Refractory Iron Deficiency Anemia 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Uterine Hemorrhage (Uterine Bleeding) 03/2021
1	Afibrinogenemia (Fibrinogen Deficiency) 03/2021
1	Hemorrhage 03/2021
1	Sepsis (Septicemia) 03/2018
1	Human Influenza (Influenza) 09/2016
1	Lymphoma (Lymphomas) 01/2016
1	Thrombocytopenia (Thrombopenia) 10/2015
1	Hypokalemia 01/2014
1	Epilepsy (Aura) 01/2014
1	Gitelman Syndrome 01/2014

1	CationsIBA 03/2023
1	Interferon Type IIBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	HemosiderinIBA 01/2022
1	Factor VIIa (Activated Factor VII)IBA 03/2021
1	Fibrinogen (Factor I)FDA Link 03/2021
1	recombinant FVIIa (rFVIIa)FDA Link 03/2021
1	ProcalcitoninIBA 03/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2016
1	Small Nuclear RNA (snRNA)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 10/2015
1	Prednisolone (Predate)FDA LinkGeneric 10/2015
1	PotassiumIBA 01/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2014
1	Aspartic Acid (Aspartate)FDA Link 01/2014
1	Member 3 Solute Carrier Family 12IBA 01/2014